149 related articles for article (PubMed ID: 16409608)
1. Retrospective study of 101 cases with incidental prostate cancer stages T1a and T1b.
Masue N; Deguchi T; Nakano M; Ehara H; Uno H; Takahashi Y
Int J Urol; 2005 Dec; 12(12):1045-9. PubMed ID: 16409608
[TBL] [Abstract][Full Text] [Related]
2. Radical prostatectomy for incidental (stage T1a-T1b) prostate cancer: analysis of predictors for residual disease and biochemical recurrence.
Capitanio U; Scattoni V; Freschi M; Briganti A; Salonia A; Gallina A; Colombo R; Karakiewicz PI; Rigatti P; Montorsi F
Eur Urol; 2008 Jul; 54(1):118-25. PubMed ID: 18314255
[TBL] [Abstract][Full Text] [Related]
3. Characteristics of patients with stage T1b incidental prostate cancer.
Argyropoulos A; Doumas K; Farmakis A; Aristas O; Kontogeorgos G; Lykourinas M
Scand J Urol Nephrol; 2005; 39(4):289-93. PubMed ID: 16118104
[TBL] [Abstract][Full Text] [Related]
4. [Clinical significance of prostate specific antigen (PSA) and PSA density in the detection of T1a and T1b prostate cancer].
Meguro N; Maeda O; Saiki S; Kinouchi T; Kuroda M; Usami M; Kotake T
Hinyokika Kiyo; 1998 Sep; 44(9):639-43. PubMed ID: 9805668
[TBL] [Abstract][Full Text] [Related]
5. Outcomes of radical prostatectomy for patients with clinical stage T1a and T1b disease.
Helfand BT; Mongiu AK; Kan D; Kim DY; Loeb S; Roehl KA; Meeks JJ; Smith ND; Catalona WJ
BJU Int; 2009 Aug; 104(3):304-9. PubMed ID: 19239451
[TBL] [Abstract][Full Text] [Related]
6. Probability of finding T1a and T1b (incidental) prostate cancer during TURP has decreased in the PSA era.
Jones JS; Follis HW; Johnson JR
Prostate Cancer Prostatic Dis; 2009; 12(1):57-60. PubMed ID: 18379587
[TBL] [Abstract][Full Text] [Related]
7. Outcome of radical prostatectomy for incidental carcinoma of the prostate.
Melchior S; Hadaschik B; Thüroff S; Thomas C; Gillitzer R; Thüroff J
BJU Int; 2009 Jun; 103(11):1478-81. PubMed ID: 19076134
[TBL] [Abstract][Full Text] [Related]
8. Clinical results of radical prostatectomy for patients with prostate cancer in Macau.
Ho SF; Lao HF; Li K; Tse MK
Chin Med J (Engl); 2008 Feb; 121(4):295-8. PubMed ID: 18304459
[TBL] [Abstract][Full Text] [Related]
9. Derivatives of prostate-specific antigen as predictors of incidental prostate cancer.
Froehner M; Buck LM; Koch R; Hakenberg OW; Wirth MP
BJU Int; 2009 Jul; 104(1):25-8. PubMed ID: 19191782
[TBL] [Abstract][Full Text] [Related]
10. Subclassification of clinical stage T1 prostate cancer: impact on biochemical recurrence following radical prostatectomy.
Magheli A; Rais-Bahrami S; Carter HB; Peck HJ; Epstein JI; Gonzalgo ML
J Urol; 2007 Oct; 178(4 Pt 1):1277-80; discussion 1280-1. PubMed ID: 17698121
[TBL] [Abstract][Full Text] [Related]
11. Predictive factors for progression in patients with clinical stage T1a prostate cancer in the PSA era.
Descazeaud A; Peyromaure M; Salin A; Amsellem-Ouazana D; Flam T; Viellefond A; Debré B; Zerbib M
Eur Urol; 2008 Feb; 53(2):355-61. PubMed ID: 17611015
[TBL] [Abstract][Full Text] [Related]
12. [Clinical study of stage a prostatic cancer detected incidentally by transurethral resection of the prostate].
Nakanishi S; Gotou T; Sawada A; Shibasaki N; Ishitoya T; Okumura K
Hinyokika Kiyo; 2009 Jan; 55(1):5-8. PubMed ID: 19227204
[TBL] [Abstract][Full Text] [Related]
13. Can insignificant prostate cancer be predicted preoperatively in men with stage T1 disease?
Epstein JI
Semin Urol Oncol; 1996 Aug; 14(3):165-73. PubMed ID: 8865479
[TBL] [Abstract][Full Text] [Related]
14. 'Vanishing' prostate cancer in radical prostatectomy specimens: incidence and long-term follow-up in 38 cases.
Bostwick DG; Bostwick KC
BJU Int; 2004 Jul; 94(1):57-8. PubMed ID: 15217431
[TBL] [Abstract][Full Text] [Related]
15. [Clinical study of prostate specific antigen failure after radical prostatectomy for prostate cancer: a single center experience].
Taue R; Takahashi M; Fukawa T; Koizumi T; Nakanishi R; Yamaguchi K; Yamamoto Y; Nakatsuji H; Kishimoto T; Izaki H; Oka N; Fukumori T; Kanayama HO
Hinyokika Kiyo; 2009 Jan; 55(1):1-4. PubMed ID: 19227203
[TBL] [Abstract][Full Text] [Related]
16. Prevalence of prostate cancer at different levels of serum prostate-specific antigen (PSA) and different free: total PSA ratios in a consecutive series of men referred for prostate biopsies.
Rydén L; Egevad L; Ekman P; Hellström M
Scand J Urol Nephrol; 2007; 41(4):302-7. PubMed ID: 17763221
[TBL] [Abstract][Full Text] [Related]
17. Adenocarcinoma of the prostate in Iceland: a population-based study of stage, Gleason grade, treatment and long-term survival in males diagnosed between 1983 and 1987.
Jonsson E; Sigbjarnarson HP; Tomasson J; Benediktsdottir KR; Tryggvadottir L; Hrafnkelsson J; Olafsdottir EJ; Tulinius H; Jonasson JG
Scand J Urol Nephrol; 2006; 40(4):265-71. PubMed ID: 16916765
[TBL] [Abstract][Full Text] [Related]
18. [Stage T1a prostatic cancer: long-term retrospective study of 27 patients].
Descazeaud A; Zerbib M; Conquy S; Amsellem-Ouazana D; Saighi D; Debré B
Prog Urol; 2001 Sep; 11(4):662-6. PubMed ID: 11761687
[TBL] [Abstract][Full Text] [Related]
19. A 6-year analysis of the clinicopathological profile of patients with prostate cancer at the University Hospital of the West Indies, Jamaica.
Coard KC; Skeete DH
BJU Int; 2009 Jun; 103(11):1482-6. PubMed ID: 19076136
[TBL] [Abstract][Full Text] [Related]
20. Multifocal neoplasia and nodal metastases in T1 esophageal carcinoma: implications for endoscopic treatment.
Altorki NK; Lee PC; Liss Y; Meherally D; Korst RJ; Christos P; Mazumdar M; Port JL
Ann Surg; 2008 Mar; 247(3):434-9. PubMed ID: 18376186
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
